Biocellgraft Delivers The World's First Injectable Oral Tissue Advancing Therapy To Treat Unmet Gum And Bone Concerns
ORAFYL. Oral Health is Overall Health Demand for OraFyl Prompts BioCellgraft and Celularity to Expedite their Strategic Planning Process fo ...
thecardiologyadvisor.com15h
Connective Tissue Disease Treatments Affect COVID-19 Hospitalization and Morality
Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with greater risks for severe COVID-19-related outcomes.